The Capital is readying for the 2024 edition of Shopping Centres Next (SCN) on the 13th and 14th of November, 2024 at Pullman ...

A Phase 2 clinical trial in first recurrent head and neck cancer, evaluating Gedeptin ® combined ... and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately ...

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...

the randomized phase I trial has been expanded to a randomized phase I/II trial in the adjuvant setting of head and neck cancer (new windowNCT04183166), which is currently enrolling patients in a ...

E. Dee Martin, partner and co-head of Bracewell’s Policy Resolution Group, and Rebecca Brown, a PRG principal, discuss the ...

Q3 2024 Earnings Call Transcript November 8, 2024 Amneal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Dr Walter Mulombo, WHO’s Head of Mission and Country Representative for Nigeria ... with the latter expected to increase from 41,000 to 52,000 cases. Vector-borne diseases, such as malaria and yellow ...

Emerging from the rough waters of the CDMO industry with a new chief executive at the helm, AGC Biologics is on a mission to reinvent itself as a manufacturing partner defined by friendliness and e | ...

The CEO of Cognizant talks about his early failures, a scientific approach, how AI will transform technology, and being ...

Agentsmyth Appoints Industry Veteran Robert Difazio As Chief Strategy Officer And Board Member Amidst Rapid Growth And Milestone Achievements ( MENAFN - FinanceWire) New York, New York, September 30th ...

Operator: Good day, and welcome to the Third Quarter 2024 Pacira Biosciences Inc. Earnings Conference Call. At this time, all ...

Standing among the most powerful Transformers, Combiners like Devastator and Titans like Trypticon are formidable opponents ...